Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism DOT1L inhibitors(DOT1 like histone lysine methyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H24N8 |
InChIKeyCNRRJWSSDCTLTQ-UHFFFAOYSA-N |
CAS Registry1163729-79-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | CN | 04 Mar 2016 | |
Leukemia | Preclinical | CN | 04 Mar 2016 |